|
|
News Breaks | | | | December 10, 2012 | | 05:09 EDT |  | CTIC | Cell Therapeutics approves amendment of shareholder rights plan
Cell Therapeutics announced that its board has approved certain amendments to CTI's existing shareholder rights plan to decrease the exercise price of the preferred stock purchase rights under the Rights Plan from $14.00 to $8.00 and to extend the "final expiration date" from the close of business on the third anniversary of January 7, to the close of business on December 3, 2015. The Rights were initially distributed as a dividend on each share of CTI's common stock outstanding on the Record Date and currently trade with each outstanding share of CTI's common stock. | |
|
News For CTIC From The Last 14 Days Check below for free stories on CTIC the last two weeks. |
|
|
| May 20, 2013 | | 05:47 EDT | | CTIC | Cell Therapeutics reports the G-BA issues final assessment report for Pixuvri
 Subscribe for More Information | |
|
|
|
|
|
|
